Literature DB >> 7061867

Microdetermination of rabbit immunoglobulin allotypes by ELISA using specific antibodies conjugated with peroxidase or with biotin.

S Jackson, J A Sogn, T J Kindt.   

Abstract

Enzyme-linked immunoadsorbent assays (ELISA) specific for the allotypes of rabbit heavy chain variable region (group a) and light chain constant region (group b) have been developed. These assays utilize affinity-purified allogeneic anti-allotype antibodies to coat polyvinyl microtiter plates. After test samples are added to the plates, the same affinity-purified antibody, coupled to the enzyme peroxidase, is used to detect binding of allotype-positive IgG samples to the coated plate. These assays can detect as little as 40 ng/ml of IgG of the appropriate allotype; the assays are highly specific and allow quantitative determination of allotype-defined IgG samples. In addition, the procedure can be modified by coupling of the antibody with biotin followed by development with avidin-peroxidase; this adaptation avoids the difficulties encountered in antibody-peroxidase conjugations. The ELISA assay is not influenced by the presence of anti-allotype antibody in the test sample, giving a distinct advantage over solid-phase radioimmunoassay procedures conventionally used for the quantitative determination of rabbit allotypes.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7061867     DOI: 10.1016/0022-1759(82)90331-3

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  16 in total

1.  Analysis of T cells and major histocompatibility complex class I and class II mRNA and protein content and distribution in antiglomerular basement membrane disease in the rabbit.

Authors:  C Eldredge; S Merritt; M Goyal; H Kulaga; T J Kindt; R Wiggins
Journal:  Am J Pathol       Date:  1991-11       Impact factor: 4.307

2.  Enzyme-linked immunosorbent assays for Snow Mountain and Norwalk agents of viral gastroenteritis.

Authors:  H P Madore; J J Treanor; K A Pray; R Dolin
Journal:  J Clin Microbiol       Date:  1986-09       Impact factor: 5.948

3.  Human monoclonal antibody directed against an envelope glycoprotein of human T-cell leukemia virus type I.

Authors:  S Matsushita; M Robert-Guroff; J Trepel; J Cossman; H Mitsuya; S Broder
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

4.  Functional and phenotypic analysis of porcine peripheral blood CD4/CD8 double-positive T cells.

Authors:  F A Zuckermann; R J Husmann
Journal:  Immunology       Date:  1996-03       Impact factor: 7.397

5.  Distribution of porcine CD4/CD8 double-positive T lymphocytes in mucosa-associated lymphoid tissues.

Authors:  F A Zuckermann; H R Gaskins
Journal:  Immunology       Date:  1996-03       Impact factor: 7.397

6.  Anti-idiotype to monoclonal anti-swine SLA antibody detects a common idiotype shared by mouse anti-SLA sera and elicits an anti-SLA activity.

Authors:  R Rabinowitz; M D Pescovitz; D H Sachs
Journal:  Immunology       Date:  1986-08       Impact factor: 7.397

7.  A genomic gene encoding the b5 rabbit immunoglobulin kappa constant region: implications for latent allotype phenomenon.

Authors:  L Emorine; J A Sogn; D Trinh; T J Kindt; E E Max
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

8.  Measurements of the frequency of human erythrocytes with gene expression loss phenotypes at the glycophorin A locus.

Authors:  R G Langlois; W L Bigbee; R H Jensen
Journal:  Hum Genet       Date:  1986-12       Impact factor: 4.132

9.  Anaphylaxis following intranasal challenge of mice sensitized with ovalbumin.

Authors:  A C McCaskill; C S Hosking; D J Hill
Journal:  Immunology       Date:  1984-04       Impact factor: 7.397

10.  Tropism of human adenovirus type 5-based vectors in swine and their ability to protect against transmissible gastroenteritis coronavirus.

Authors:  J M Torres; C Alonso; A Ortega; S Mittal; F Graham; L Enjuanes
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.